Glaxosmithkline Presents Data AAAAI on Efficacy of Nucala in Severe Asthma Patients Stratified by Eosinophil Levels; Study  Showed Severe Asthma Patients Who Received Nucala Had Significant Improvement in Exacerbation Rates vs Placebo